Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban versus phenprocoumon in atrial fibrillation patients with end-stage kidney disease on hemodialysis
2015-005503-84Phase 3Completed
- Sponsor
- Kompetenznetz Vorhofflimmern
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban, phenprocoumon in Atrial fibrillation (AFib), sponsored by Kompetenznetz Vorhofflimmern. Started Nov 2016; status: completed.
02
Drugs
apixabanphenprocoumon
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2015-005503-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005503-84.